Elevated levels of inflammation marker offsets benefits of good cholesterol

April 3, 2016
Cholesterol test

People with high levels of "good" cholesterol, or high-density lipoprotein, are not as safe from heart disease when high levels of a newly identified biomarker of inflammation in the arteries are also found in their bloodstream, according to a new study.

In the study of nearly 3,000 patients, researchers from the Intermountain Medical Center Heart Institute in Salt Lake City discovered that the presence of high levels of the biomarker glycoprotein acetylation, or GlycA, was associated with an increased risk of or stroke.

Inflammation of the artery walls is a contributing factor to heart attack and stroke because it increases the likelihood that plaque on the arterial walls will rupture, induce clot formation and block blood flow.

"We already know that HDL provides an anti-inflammatory effect on the arteries," said Brent Muhlestein, MD, co-director of cardiovascular research at the Intermountain Medical Center Heart Institute. "But our research suggests there's an interaction between GlycA and small HDL particles that reduces the anti-inflammatory capabilities of HDL and increases a person's chances of having a heart attack or stroke."

Results of the study will be presented at the American College of Cardiology Scientific Sessions in Chicago on Saturday, April 2, at 2:45 p.m., CDT.

Using a test developed by LipoScience known as NMR spectroscopy, researchers measured lipoprotein particles and GlycA in 2,848 patients whose average age was 63 years old. Sixty-six percent of the patients were male and 65 percent had .

"The results of our study reinforce the importance of the recommendations we offer to our patients working to reduce in their arteries by exercising regularly and eating heart-healthy foods," said Dr. Muhlestein. "Some ways of increasing the HDL levels that will provide the anti-inflammatory protection include eating foods higher in Omega 3s and following the Mediterranean diet, which revolves around plant-based foods, healthy fats, and limited amounts of salt and red meat."

Historically, C-reactive protein has been used as an indicator of inflammation in the body, and is predictive of future heart-related adverse events. Now, GlycA, a marker of inflammation identified through NMR, appears to show the same predictive ability.

However, researchers are currently seeking to determine if C-reactive protein and GlycA are completely independent of each other in terms of their impact on inflammation and .

"GlycA is a new particle we didn't know much about, but now that we know there are epidemiologic associations, we need to look at additional ways to evaluate and understand the way it functions and interacts in the bloodstream," said Dr. Muhlestein.

Explore further: Researchers identify new protein markers that may improve understanding of heart disease

Related Stories

A biomarker for premature death

October 22, 2015

A single blood test could reveal whether an otherwise healthy person is unusually likely to die of pneumonia or sepsis within the next 14 years. Based on an analysis of 10,000 individuals, researchers have identified a molecular ...

Signs of stress in the brain may signal future heart trouble

March 24, 2016

New research shows that individuals with a greater degree of activity in the stress center of the brain also have more evidence of inflammation in their arteries and were at higher risk for cardiovascular events, including ...

Recommended for you

Study identifies key player in heart enlargement

June 27, 2017

The heart is a dynamic muscle that grows and shrinks in response to stressors such as exercise and disease. The secret to its malleability lies in individual cells, which get bigger or smaller depending on the heart's needs. ...

Mechanism shown to reverse disease in arteries

June 26, 2017

A certain immune reaction is the key, not to slowing atherosclerosis like cholesterol-lowering drugs do, but instead to reversing a disease that gradually blocks arteries to cause heart attacks and strokes.

Where are the new therapies for heart disease?

June 26, 2017

Despite dramatic reductions in the death rate from cardiovascular disease, which includes heart disease and stroke, it remains the leading causes of death, and experts have expressed concern that the number of new therapies ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.